Screening for bladder cancer using urine-based tumor markers

R. S. Svatek, Y. Lotan, P. I. Karakiewizc, S. F. Shariat

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer. The ultimate goal of cancer screening is to decrease cancer-related mortality by detecting disease prior to the time that the disease would normally prompt evaluation from symptoms. There are several features of urothelial carcinoma of the bladder which make screening for this disease an attractive alternative to the current approach to this disease. The disease targets a defined population and survival for patients with this disease is strongly associated with disease stage at presentation. In addition, quick, easy, and painless screening tests are theoretically possible using tumor-related markers because of the direct exposure of caner cells to urine. Indeed, recent insights into the biology of bladder cancer initiation and progression have resulted in the identification of several urine-based markers which have promise for detecting the presence of bladder cancer. Nevertheless, adoption of screening programs prior to establishing evidence of effectiveness and large-scale financial considerations has substantial damaging consequences. This article reviews the current literature regarding screening for bladder cancer using urine-based markers.

Original languageEnglish (US)
Pages (from-to)247-253
Number of pages7
JournalMinerva Urologica e Nefrologica
Issue number4
StatePublished - Dec 2008
Externally publishedYes


  • Screeening
  • Tumor markers, biological
  • Urinary bladder neoplasms, diagnosis

ASJC Scopus subject areas

  • Nephrology
  • Urology


Dive into the research topics of 'Screening for bladder cancer using urine-based tumor markers'. Together they form a unique fingerprint.

Cite this